Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Carl W. Langren currently holds 11,494 shares of NEWLINK GENETICS CORP ((NLNK)), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carl W. Langren has been a net seller of (NLNK) stock. They have purchased $0 and sold $1.3M worth of shares.
Carl W. Langren's most recent insider trade was on Apr 1, 2021, when they sold 683 shares at $12.25 per share.
Carl W. Langren serves as Executive at NEWLINK GENETICS CORP ((NLNK)). They have executed 32 insider transactions totaling $1.3M over their tenure at the company.
Carl W. Langren holds the position of Executive at NEWLINK GENETICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Carl W. Langren has shown a selling trading pattern, with $0 in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Carl W. Langren was on Oct 11, 2014, when they sold $1.1M worth of (NLNK) shares. This transaction involved 56,691 shares at $18.96 per share.
Carl W. Langren currently owns 11,494 shares of NEWLINK GENETICS CORP ((NLNK)), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Carl W. Langren's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Carl W. Langren has 32 Form 4 filings on record as an insider at NEWLINK GENETICS CORP.
Set alerts for Carl W. Langren and 40,000+ other insiders.